Beam Therapeutics (BEAM) EBT Margin Growth (1y) (2020 - 2026)
Beam Therapeutics (BEAM) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - | 115,661.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 115,661.00 |
| Dec 31, 2025 | 51,460.00 |
| Sep 30, 2025 | -48,492.00 |
| Jun 30, 2025 | -43,513.00 |
| Mar 31, 2025 | -21,521.00 |
| Dec 31, 2024 | -34,610.00 |
| Sep 30, 2024 | -11,859.00 |
| Jun 30, 2024 | -36,163.00 |
| Mar 31, 2024 | -88,288.00 |
| Dec 31, 2023 | 23,199.00 |
| Sep 30, 2023 | -4,198.00 |
| Jun 30, 2023 | 64,663.00 |
| Mar 31, 2023 | 76,607.00 |
| Dec 31, 2022 | -5,970.00 |
| Sep 30, 2022 | 316,829.00 |
| Jun 30, 2022 | 102.12 Mn |
| Mar 31, 2022 | 336.68 Mn |
| Dec 31, 2021 | 68.16 Mn |
| Sep 30, 2021 | 64.91 Mn |
| Jun 30, 2021 | -56.18 Mn |